X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (128) 128
animals (87) 87
humans (65) 65
inflammation (49) 49
male (47) 47
mice (46) 46
asthma (42) 42
leukotrienes (39) 39
pharmacology & pharmacy (35) 35
rats (33) 33
montelukast (31) 31
expression (30) 30
receptors, leukotriene - metabolism (26) 26
immunology (23) 23
leukotriene antagonists - pharmacology (23) 23
leukotrienes - metabolism (23) 23
focal cerebral-ischemia (21) 21
5-lipoxygenase (20) 20
female (20) 20
neurosciences (20) 20
respiratory system (19) 19
rodents (18) 18
acetates - pharmacology (17) 17
disease models, animal (17) 17
leukotriene (17) 17
leukotriene antagonists - therapeutic use (17) 17
quinolines - pharmacology (17) 17
rats, sprague-dawley (17) 17
antagonist (16) 16
cytokines (16) 16
health aspects (16) 16
lipids (16) 16
activation (15) 15
cell biology (15) 15
cerebral ischemia (15) 15
cysteinyl leukotriene receptor-1 (15) 15
receptors, leukotriene - genetics (15) 15
biochemistry & molecular biology (14) 14
ischemia (14) 14
medicine, research & experimental (14) 14
signal transduction (14) 14
acetates - therapeutic use (13) 13
allergy (13) 13
brain (13) 13
cysteinyl leukotrienes (13) 13
quinolines - therapeutic use (13) 13
brain - pathology (12) 12
pranlukast (12) 12
receptors, leukotriene b4 - metabolism (12) 12
synthesis (12) 12
allergic rhinitis (11) 11
arachidonate 5-lipoxygenase - metabolism (11) 11
article (11) 11
brain ischemia - pathology (11) 11
cells (11) 11
multidisciplinary sciences (11) 11
oxidative stress (11) 11
physiological aspects (11) 11
research (11) 11
review (11) 11
stroke (11) 11
abridged index medicus (10) 10
artery occlusion (10) 10
asthma - drug therapy (10) 10
atherosclerosis (10) 10
cysteinyl leukotriene receptor (10) 10
development and progression (10) 10
in-vitro (10) 10
injury (10) 10
proteins (10) 10
research article (10) 10
studies (10) 10
time factors (10) 10
apoptosis (9) 9
asthma - metabolism (9) 9
brain-injury (9) 9
cells, cultured (9) 9
chromones - pharmacology (9) 9
cysteinyl-leukotrienes (9) 9
genetic aspects (9) 9
injuries (9) 9
leukotriene b4 - metabolism (9) 9
mice, knockout (9) 9
neurons (9) 9
physiology (9) 9
receptors (9) 9
receptors, leukotriene - drug effects (9) 9
respiratory tract diseases (9) 9
analysis (8) 8
brain - drug effects (8) 8
brain ischemia - metabolism (8) 8
chemistry, multidisciplinary (8) 8
cyslt receptor (8) 8
gene expression (8) 8
immunohistochemistry (8) 8
leukotriene receptor antagonist (8) 8
lipoxygenase (8) 8
lymphocytes (8) 8
medicine & public health (8) 8
oxygen-glucose deprivation (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 2/2017, Volume 390, Issue 2, pp. 197 - 205
Journal Article
BIOCHEMICAL PHARMACOLOGY, ISSN 0006-2952, 07/2013, Volume 86, Issue 2, pp. 286 - 296
Because of their favourable safety profile and beneficial anti-inflammatory properties, the CysLT(1) receptor antagonists (LTRA), montelukast, zafirlukast and... 
mPGES-1 | Prostaglandin | SAFETY | Zafirlukast | Montelukast | CYCLOOXYGENASE | RECEPTOR ANTAGONIST | PGE | Leukotriene | PHARMACOKINETICS | Pranlukast | INFLAMMATION | ASTHMA | CRTH2 | PHARMACOLOGY & PHARMACY | PROSTAGLANDIN E-2
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 04/2011, Volume 63, Issue 4, pp. 550 - 557
Objectives  Previously we demonstrated the neuroprotective effect of montelukast, a cysteinyl leukotriene receptor‐1 (CysLT 1 ) antagonist, on acute brain... 
focal cerebral ischaemia | antagonist | montelukast | neuroprotection | cysteinyl leukotriene receptor 1 | Montelukast | Neuroprotection | Antagonist | Focal cerebral ischaemia | Cysteinyl leukotriene receptor 1 | CELLS | KAPPA-B ACTIVATION | FREE-RADICAL SCAVENGER | SODIUM MK-0476 | OXYGEN-GLUCOSE DEPRIVATION | STROKE | ASTROCYTE PROLIFERATION | ASTHMA | PHARMACOLOGY & PHARMACY | PRANLUKAST | EXPRESSION | Brain Injury, Chronic - complications | Male | Quinolines - administration & dosage | Quinolines - pharmacology | Antipyrine - analogs & derivatives | Brain Injury, Chronic - prevention & control | Leukotriene Antagonists - pharmacology | Behavior, Animal - drug effects | Acetates - therapeutic use | Free Radical Scavengers - therapeutic use | Infarction, Middle Cerebral Artery - drug therapy | Drug Evaluation, Preclinical | Chromones - therapeutic use | Disease Models, Animal | Leukotriene Antagonists - therapeutic use | Antipyrine - therapeutic use | Brain Injury, Chronic - pathology | Administration, Oral | Injections, Intraperitoneal | Rats | Infarction, Middle Cerebral Artery - pathology | Rats, Sprague-Dawley | Mice, Inbred ICR | Animals | Acetates - administration & dosage | Atrophy - prevention & control | Acetates - pharmacology | Mice | Quinolines - therapeutic use | Nerve Degeneration - drug therapy | Index Medicus
Journal Article
Brain Research, ISSN 0006-8993, 2005, Volume 1053, Issue 1, pp. 116 - 125
Journal Article
Journal Article
Pharmacology, ISSN 0031-7012, 01/2005, Volume 73, Issue 1, pp. 31 - 40
Journal Article
Journal Article
Journal Article
Journal Article
Experimental Neurology, ISSN 0014-4886, 06/2014, Volume 256, pp. 7 - 16
Journal Article